Park Ha Biological Technology Co., Ltd.
PHH
$0.57
-$0.0107-1.84%
NASDAQ
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -3.14% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -3.14% | -- | -- | -- | |
| Cost of Revenue | -37.17% | -- | -- | -- | |
| Gross Profit | 1.78% | -- | -- | -- | |
| SG&A Expenses | 44.77% | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 24.21% | -- | -- | -- | |
| Operating Income | -32.76% | -- | -- | -- | |
| Income Before Tax | -32.85% | -- | -- | -- | |
| Income Tax Expenses | -4.49% | -- | -- | -- | |
| Earnings from Continuing Operations | -43.83% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -43.83% | -- | -- | -- | |
| EBIT | -32.76% | -- | -- | -- | |
| EBITDA | -32.00% | -- | -- | -- | |
| EPS Basic | -43.53% | -- | -- | -- | |
| Normalized Basic EPS | -32.43% | -- | -- | -- | |
| EPS Diluted | -43.53% | -- | -- | -- | |
| Normalized Diluted EPS | -32.43% | -- | -- | -- | |
| Average Basic Shares Outstanding | 0.00% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 0.00% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |